Assessment of Global Longitudinal Strain for the Prediction of Anthracycline Induced Cardiotoxicity

CompletedOBSERVATIONAL
Enrollment

86

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

May 31, 2015

Study Completion Date

October 31, 2016

Conditions
Cardiovascular Diseases
Interventions
DRUG

Anthracycline administration

Patients suffering from lymphoma or acute leukemia and requiring anthracycline administration were included

Trial Locations (1)

Unknown

CH Versailles, Le Chesnay

All Listed Sponsors
lead

Versailles Hospital

OTHER

NCT02875171 - Assessment of Global Longitudinal Strain for the Prediction of Anthracycline Induced Cardiotoxicity | Biotech Hunter | Biotech Hunter